Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma.
Saved in:
| Title: | Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. |
|---|---|
| Authors: | Furqan M; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Elliott RJR; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Nagle PWK; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Dawson JC; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Masalmeh R; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Garcia VA; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Munro AF; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Drake C; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Morrison GM; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK.; Centre for Regenerative Medicine, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK., Pollard SM; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK.; Centre for Regenerative Medicine, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK., Ebner D; Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK., Brunton VG; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Frame MC; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK., Carragher NO; Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH4 2XR, UK. |
| Source: | Pharmaceutics [Pharmaceutics] 2025 Apr 23; Vol. 17 (5). Date of Electronic Publication: 2025 Apr 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1999-4923 |
|---|---|
| DOI: | 10.3390/pharmaceutics17050549 |
